Clinical Trials Directory

Trials / Completed

CompletedNCT01378832

Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Postoperative Colorectal Cancer Infection in Elective Surgery

Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Infection in Elective Surgery

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Universidad Miguel Hernandez de Elche · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Intrabdominal antibiotic irrigation will reduce wound and intrabdominal infection.

Detailed description

A prospective, randomized study was performed between January and December 2010. Patient inclusion criteria were a diagnosis of colorectal neoplasms and plans to undergo an elective curative surgery. Patients were divided into 2 groups: Group 1 (intra-abdominal irrigation with normal saline) and Group 2 (intraperitoneal irrigation with a solution of 240 mg gentamicin and 600 mg clindamycin). The occurrence of wound infections and intra-abdominal abscesses were investigated. Following the anastomosis, a microbiological sample of the peritoneal surface was obtained (sample 1). A second sample was collected following an irrigation with normal saline (sample 2). Finally, the peritoneal cavity was irrigated with a gentamicin-clindamycin solution and a third sample was obtained (sample 3).

Conditions

Interventions

TypeNameDescription
PROCEDUREIntra-peritoneal antibiotic lavageThe lavage was performed immediately prior to closure of the abdominal wall. Prior to the lavage, a microbiological sample from the peritoneal surface (parietal and visceral) was obtained with a swab (sample 1), followed by a lavage with 500 ml normal saline, similar to the one performed in Group 1. After this lavage, a new microbiological sample was obtained from the peritoneal surface (sample 2), and a second lavage with an antibiotic solution, including gentamicin (240 mg) and clindamycin (600 mg) dissolved in 500 ml normal saline was performed. During this lavage, the solution was allowed to sit in the abdominal cavity for 3 minutes. After aspirating the lavage, a third microbiological sample was obtained in the same way as the two previous ones (sample 3).

Timeline

Start date
2010-01-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2011-06-22
Last updated
2011-06-22

Source: ClinicalTrials.gov record NCT01378832. Inclusion in this directory is not an endorsement.